Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

CRVS holding history

Corvus Pharmaceuticals, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRVS overviewAll 13F holders of CRVSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of CRVS by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−81,310−100.0%Sold outHolders
Q1 202681,310$1.19M<0.1%+81,310NewHolders
Q3 20250$00.0%−165,188−100.0%Sold outHolders
Q2 2025165,188$660.8K<0.1%−99,800−37.7%ReducedHolders
Q1 2025264,988$842.7K<0.1%−125,700−32.2%ReducedHolders
Q4 2024390,688$2.09M<0.1%+4,100+1.1%AddedHolders
Q3 2024386,588$2.04M<0.1%−177,344−31.4%ReducedHolders
Q2 2024563,932$1.03M<0.1%−73,100−11.5%ReducedHolders
Q1 2024637,032$1.13M<0.1%+49,600+8.4%AddedHolders
Q4 2023587,432$1.03M<0.1%+165,689+39.3%AddedHolders
Q3 2023421,743$616.0K<0.1%−67,930−13.9%ReducedHolders
Q2 2023489,673$1.12M<0.1%−16,359−3.2%ReducedHolders
Q1 2023506,032$460.0K<0.1%−142,600−22.0%ReducedHolders
Q4 2022648,632$551.0K<0.1%−326,887−33.5%ReducedHolders
Q3 2022975,519$798.0K<0.1%+12,587+1.3%AddedHolders
Q2 2022962,932$953.0K<0.1%+61,800+6.9%AddedHolders
Q1 2022901,132$1.48M<0.1%−142,600−13.7%ReducedHolders
Q4 20211,043,732$2.52M<0.1%+429,362+69.9%AddedHolders
Q3 2021614,370$2.97M<0.1%−43,700−6.6%ReducedHolders
Q2 2021658,070$1.76M<0.1%−5,400−0.8%ReducedHolders
Q1 2021663,470$2.04M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.